Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ: NDRA )

3.490 -0.290 (-7.67%)
Streaming Delayed Price Updated: 10:19 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 59,898
Open 3.490
Bid (Size) 3.370 (1)
Ask (Size) 3.500 (4)
Prev. Close 3.780
Today's Range 3.280 - 3.630
52wk Range 2.970 - 664.83
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
On Wednesday, there are stocks with unusual volume. Let's take a look.
These stocks have an unusual volume in today's session 
Via Chartmill
What's going on in today's pre-market session
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill

Performance

YTD
-45.81%
-45.81%
1 Month
-22.27%
-22.27%
3 Month
-37.68%
-37.68%
6 Month
-69.78%
-69.78%
1 Year
-99.22%
-99.22%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
Via Benzinga
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Via Benzinga
Data I/O And 2 Other Stocks Under $5 Executives Are Buying
Via Benzinga
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.